Try it
OBG · Antenatal immunohematology
Sample itemWhat product is given to eligible Rh-negative mothers to reduce alloimmunization risk?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Anti-D immunoglobulin
Anti-D immunoglobulin reduces maternal sensitization to Rh-positive fetal red cells and lowers the risk of hemolytic disease in future pregnancies.
Option by option
A. Folic acid
Folic acid reduces neural-tube-defect risk.
B. Anti-D immunoglobulin (correct)
Correct: anti-D reduces Rh alloimmunization in eligible Rh-negative mothers.
C. Magnesium sulfate
Magnesium sulfate prevents seizures in severe preeclampsia.
D. Oxytocin
Oxytocin stimulates uterine contraction rather than preventing sensitization.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More OBG questions
- Antenatal careA woman's last menstrual period began on 10 January 2026. Using Naegele's rule, what is…
- Obstetric drugsCarboprost (15-methyl PGF2α) is contraindicated in which condition?
- Hypertensive disorders of pregnancyA primigravida at 34 weeks has a blood pressure of 150/100 mmHg on two occasions and 2+…
- Obstetric immunologyAn Rh-negative mother delivers an Rh-positive baby. When should anti-D immunoglobulin be…